Nifedipine-suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits. 1987

Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
August 1989, Atherosclerosis,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
September 1995, Journal of cardiovascular pharmacology,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
June 1990, Atherosclerosis,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
April 2005, Molecular nutrition & food research,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
March 1992, The American journal of pathology,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
May 2013, Psychoneuroendocrinology,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
July 2002, Atherosclerosis,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
August 2007, Atherosclerosis,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
March 1998, Atherosclerosis,
Y Ishikawa, and N Watanabe, and R Okamoto, and Y Watanabe, and H Fukuzaki
July 1992, Japanese heart journal,
Copied contents to your clipboard!